| Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease D Fatkin, C MacRae, T Sasaki, MR Wolff, M Porcu, M Frenneaux, ... New England Journal of Medicine 341 (23), 1715-1724, 1999 | 1574 | 1999 |
| Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review AS Zubair, LS McAlpine, T Gardin, S Farhadian, DE Kuruvilla, S Spudich JAMA neurology 77 (8), 1018-1027, 2020 | 1140 | 2020 |
| Central nervous system viral invasion and inflammation during acute HIV infection V Valcour, T Chalermchai, N Sailasuta, M Marovich, S Lerdlum, ... The Journal of infectious diseases 206 (2), 275-282, 2012 | 573 | 2012 |
| Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study M Gisslén, RW Price, U Andreasson, N Norgren, S Nilsson, L Hagberg, ... EBioMedicine 3, 135-140, 2016 | 451 | 2016 |
| HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment A Edén, D Fuchs, L Hagberg, S Nilsson, S Spudich, B Svennerholm, ... Journal of Infectious Diseases 202 (12), 1819-1825, 2010 | 351 | 2010 |
| Nervous system consequences of COVID-19 S Spudich, A Nath Science 375 (6578), 267-269, 2022 | 322 | 2022 |
| Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load MJ Peluso, F Ferretti, J Peterson, E Lee, D Fuchs, A Boschini, M Gisslén, ... Aids 26 (14), 1765-1774, 2012 | 290 | 2012 |
| HIV-1 replication in the central nervous system occurs in two distinct cell types G Schnell, S Joseph, S Spudich, RW Price, R Swanstrom PLoS pathogens 7 (10), e1002286, 2011 | 278 | 2011 |
| Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection L Hagberg, P Cinque, M Gisslen, BJ Brew, S Spudich, A Bestetti, ... AIDS research and therapy 7, 1-12, 2010 | 255 | 2010 |
| HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment S Spudich, F González-Scarano Cold Spring Harbor perspectives in medicine 2 (6), a007120, 2012 | 248 | 2012 |
| Immune activation of the central nervous system is still present after> 4 years of effective highly active antiretroviral therapy A Edén, RW Price, S Spudich, D Fuchs, L Hagberg, M Gisslén Journal of Infectious Diseases 196 (12), 1779-1783, 2007 | 208 | 2007 |
| Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection CB Sturdevant, SB Joseph, G Schnell, RW Price, R Swanstrom, ... PLoS pathogens 11 (3), e1004720, 2015 | 204 | 2015 |
| Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND) Z Zayyad, S Spudich Current Hiv/Aids Reports 12, 16-24, 2015 | 203 | 2015 |
| Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection MJ Peluso, DJ Meyerhoff, RW Price, J Peterson, E Lee, AC Young, ... The Journal of infectious diseases 207 (11), 1703-1712, 2013 | 189 | 2013 |
| Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1–infected patients with detectable viremia PW Hunt, PR Harrigan, W Huang, M Bates, DW Williamson, JM McCune, ... The Journal of infectious diseases 194 (7), 926-930, 2006 | 188 | 2006 |
| Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment SS Spudich, AC Nilsson, ND Lollo, TJ Liegler, CJ Petropoulos, SG Deeks, ... BMC infectious diseases 5, 1-19, 2005 | 182 | 2005 |
| Assessment of brain injury using portable, low-field magnetic resonance imaging at the bedside of critically ill patients KN Sheth, MH Mazurek, MM Yuen, BA Cahn, JT Shah, A Ward, JA Kim, ... JAMA neurology 78 (1), 41-47, 2021 | 180 | 2021 |
| Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden S Spudich, M Gisslen, L Hagberg, E Lee, T Liegler, B Brew, D Fuchs, ... Journal of Infectious Diseases 204 (5), 753-760, 2011 | 179 | 2011 |
| Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection G Schnell, RW Price, R Swanstrom, S Spudich Journal of virology 84 (5), 2395-2407, 2010 | 178 | 2010 |
| Amyloid and tau cerebrospinal fluid biomarkers in HIV infection M Gisslén, J Krut, U Andreasson, K Blennow, P Cinque, BJ Brew, ... BMC neurology 9, 1-13, 2009 | 173 | 2009 |
Magnus GisslénVerified email at infect.gu.se
